104
Views
11
CrossRef citations to date
0
Altmetric
Review

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 183-191 | Published online: 19 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Kévin Jean, Ahmed Tawheed, Liem Binh Luong Nguyen, Tarek Heikal, Usama Eldaly, Neveen Elhadidy, Ahmed Elghaieb, Ahmed Aboudonia, Laura Tondeur, Amélie Dublineau, Arnaud Fontanet & Mohamed El-Kassas. (2023) Changes in Presentation, Treatment, and Survival of Patients with Hepatocellular Carcinoma in Damietta, Egypt, 2007–2019: A Retrospective Monocentric Cohort Study. Journal of Hepatocellular Carcinoma 10, pages 99-111.
Read now
Mohamed El Kassas, Mohamed Eltabbakh, Mohamed Elbadry, Ahmed Tawheed & Tamer Elbaz. (2022) Establishing a research production line in real-life settings: the case of Hepatitis C management in a viral hepatitis specialized Egyptian center. Current Medical Research and Opinion 38:4, pages 553-563.
Read now
Gamal Esmat, Tamer Elbaz, Aisha Elsharkawy, Mohamed Abdullah & Mohamed El Kassas. (2020) Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt. Expert Review of Anti-infective Therapy 18:7, pages 637-642.
Read now

Articles from other publishers (8)

Luisa J. Ströh & Thomas Krey. (2023) Structural insights into hepatitis C virus neutralization. Current Opinion in Virology 60, pages 101316.
Crossref
Mohamed Elbadry, Abdelmajeed M. Moussa, Mohamed Eltabbakh, Amira Al Balakosy, Mohammad Abdalgaber, Nermeen Abdeen, Reem Y. El Sheemy, Shimaa Afify & Mohamed El-Kassas. (2022) The art of managing hepatitis C virus in special population groups: a paradigm shift. Egyptian Liver Journal 12:1.
Crossref
Reem Ezzat, Mohamed Eltabbakh & Mohamed El Kassas. (2021) Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures. World Journal of Gastrointestinal Oncology 13:12, pages 1919-1938.
Crossref
Nadia O. M. Mangoud, Sahar A. Ali, Mohamed El Kassas & Sameh H. Soror. (2021) Chitinase 3‐like‐1, Tolloid‐like protein 1, and intergenic gene polymorphisms are predictors for hepatocellular carcinoma development after hepatitis C virus eradication by direct‐acting antivirals . IUBMB Life 73:2, pages 474-482.
Crossref
Jiao Feng, Jingjing Li, Liwei Wu, Qiang Yu, Jie Ji, Jianye Wu, Weiqi Dai & Chuanyong Guo. (2020) Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Yong-yu Mei, You-ming Chen, Yuan-kai Wu, Xiao-hong Zhang & Wen-xiong Xu. (2020) Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection. Canadian Journal of Gastroenterology and Hepatology 2020, pages 1-8.
Crossref
Luisa J. Ströh & Thomas Krey. (2020) HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development. International Journal of Molecular Sciences 21:18, pages 6781.
Crossref
Shanshan Jia, Wei Zhou, Jiarui Wu, Xinkui Liu, Siyu Guo, Jingyuan Zhang, Shuyu Liu, Mengwei Ni, Ziqi Meng, Xiaomeng Zhang, Xiantao Zeng & Zhiwei Jing. (2020) A biomolecular network-based strategy deciphers the underlying molecular mechanisms of Bupleuri Radix/ Curcumae Radix medicine pair in the treatment of hepatitis C. European Journal of Integrative Medicine 33, pages 101043.
Crossref